Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
196.31
+1.13 (+0.58%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
59
60
Next >
20 Recession-Proof Stocks to Buy Now for 2023
January 04, 2023
These recession-proof stocks typically hold up better in a recession and add diversity to your portfolio.
Via
The Motley Fool
Where to Invest $100,000 in 2023
January 04, 2023
The holidays are over. Let's put our money to work.
Via
The Motley Fool
3 Outstanding Dividend Growth Stocks to Buy for 2023
January 04, 2023
Steadily growing dividend payments from these stocks could do wonders for your passive income portfolio down the road.
Via
The Motley Fool
Beat the Dow Jones With This Unstoppable Dividend Stock
January 03, 2023
This drugmaker is accustomed to outperforming the broader market.
Via
The Motley Fool
23 Top Dividend Stocks to Buy and Hold in 2023
January 03, 2023
These dividend stocks could reward investors in the new year and beyond.
Via
The Motley Fool
$1000 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
December 23, 2022
Via
Benzinga
The 10 Best Stocks to Buy in January 2023
January 02, 2023
These are the top holdings in my million-dollar stock portfolio.
Via
The Motley Fool
12 Forever Stocks For Generational Rising Passive Income
December 31, 2022
A look at 12 “forever” stocks coming from various industries, including technology, healthcare, and consumer goods, with solid track records of growth and stability.
Via
Talk Markets
3 Dividend Stocks to Buy Hand Over Fist in 2023
December 31, 2022
Two of these three are members of dividend royalty.
Via
The Motley Fool
3 Best Value Stocks to Buy Before 2023
December 31, 2022
Now's the time for investors to think strategically about how -- and how much -- the investing landscape has changed in just the past few months.
Via
The Motley Fool
2 "Safe" Stocks That Are Anything But
December 30, 2022
Sometimes, business models that sound safe still fail to deliver for shareholders.
Via
The Motley Fool
3 High-Yield Dividend Stocks to Supercharge Your Passive Income Portfolio
December 29, 2022
Here are three dividend-paying stocks that could help fuel your retirement dreams.
Via
The Motley Fool
Our Predictions for the Top 7 Dividend Stocks for 2023
December 28, 2022
Dividend stocks will be an ideal way for investors to practice patient in 2023. Here are my dividend stock predictions for 2023.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
December 24, 2022
These companies are safe havens during tough times, with above-average dividends.
Via
The Motley Fool
If You Invested $25,000 in AbbVie In 2020, This Is How Much You Would Have Today
December 23, 2022
In May 2020, the company closed on its acquisition of Botox maker Allergan.
Via
The Motley Fool
Here's Why the Bear Market Could End in 2023
December 21, 2022
Now could be the opportune time to load up on some quality growth stocks.
Via
The Motley Fool
This Unstoppable Growth Stock Is Nearing a Once-In-a-Decade Buying Opportunity
December 21, 2022
The risk of a stalled top line in 2023 means the potential for reward for those who can see beyond it.
Via
The Motley Fool
2 Mammoth Stocks With Dividends to Buy Before 2022 Ends
December 21, 2022
Blue chip healthcare stocks Johnson & Johnson and Cigna are always in season.
Via
The Motley Fool
Top 15 Investing Tips for Beginners in 2023 and Beyond
December 21, 2022
These investing tips for beginners will help you be a better long-term investor.
Via
The Motley Fool
2 Exceptional Dividend Growth Stocks to Buy Now
December 20, 2022
These companies have histories of rapid payout increases and the means to continue them.
Via
The Motley Fool
Tuesday Talk: Where is Santa?
December 20, 2022
Monday continued the downtrend for the major indices on Wall Street which concluded a second week of losses on Friday. As for an annual Santa rally, that seems nowhere to be found.
Via
Talk Markets
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro
December 19, 2022
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning.
Via
Talk Markets
AbbVie's Antipsychotic Drug Scores FDA Approval As Adjunct Therapy For Depression Patients
December 19, 2022
Via
Benzinga
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
December 18, 2022
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.
Via
InvestorPlace
6 Stocks Warren Buffett Completely Exited in 2022
December 17, 2022
Despite being an active buyer this year, Buffett's company Berkshire Hathaway also sold several of its holdings as it repositioned its portfolio.
Via
The Motley Fool
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
December 16, 2022
Dividends are an investor's best friend in any market environment.
Via
The Motley Fool
Why Pfizer Stock Is Riskier Than AbbVie
December 16, 2022
Pfizer has a lot more revenue at risk over the next several years than AbbVie does.
Via
The Motley Fool
2 Dividend Stocks That Could Double Your Return in 10 Years
December 16, 2022
Both companies should hurdle their patent cliff concerns.
Via
The Motley Fool
Looking Into AbbVie's Recent Short Interest
December 15, 2022
AbbVie's (NYSE:ABBV) short percent of float has risen 5.48% since its last report. The company recently reported that it has 13.66 million shares sold short, which is 0.77% of all regular shares that...
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.